Astec LifeSciences Limited / Fundamentals
Income statement
- Net revenue
€37.22M - Cost of goods sold
€34.05M - Gross profit
€3.17M - SG&A expenses
€3.15M - R&D expenses
€0.00 - EBITDA
-€6.05M - D&A
€4.20M - EBIT
-€7.06M - Interest expenses
€2.57M - EBT
-€13.76M - Tax expenses
-€612.74K - Net income
-€13.15M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€13.15M - Changes in working capital
€0.00 - Operating cash flow
€0.00 - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€0.00 - Net financing cash flow
€0.00 - Foreign exchange effects
€0.00 - Net change in cash
€0.00 - Cash at end of period
€0.00 - Free cash flow
€0.00
Balance sheet
- Cash and cash equivalents
€264.07K - Cash and short-term investments
€264.07K - Total receivables
€14.39M - Inventory
€15.60M - Other current assets
€3.04M - Total current assets
€33.30M - Property, plant & equipment
€48.48M - Goodwill
€0.00 - Intangible assets
€2.29M - Long-term investments
€517.32 - Other non-current assets
€1.97M - Total non-current assets
€52.74M - Total assets
€86.03M - Accounts payable
€7.97M - Short-term debt
€26.80M - Other current liabilities
€932.71K - Total current liabilities
€35.70M - Long-term debt
€27.33M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€67.81K - Total non-current liabilities
€27.40M - Total liabilities
€63.09M - Common stock
€1.91M - Retained earnings
€0.00 - Other equity
€21.00M - Total equity
€22.94M - Total liabilities and shareholders' equity
€86.03M
Company information
- Market capitalization
€181.09M - Employees
606 - Enterprise Value
€20.81B
Company ratios
- Gross margin
-
8.5% Much worse than peer group: 36.1% - EBITDA margin
-
-16.3% Much worse than peer group: 19.2% - EBIT margin
-
-19.0% Much worse than peer group: 15.6% - EBT margin
-
-37.0% Much worse than peer group: 15.1% - Net margin
-
-35.3% Much worse than peer group: 11.0% - ROE
-
-57.3% Much worse than peer group: 388.5% - ROA
-
-15.3% Much worse than peer group: 11.3% - Asset turnover
-
43.3% Much worse than peer group: 99.3% - FCF margin
-
0.0% - FCF yield
0.0% - Efficiency ratio
116.3% - Net sales per employee
-
€61.42K - Net income per employee
-
-€21.70K